# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4200947 | Binding | Inhibition of mouse His-tagged IDE (42 to 1019 residues) using fluorophore/quencher-tagged RPPGFSAFK(Dnp)-OH peptide as substrate preincubated for 10 mins followed by substrate addition measured over 5 mins by TR-FRET assay | Mus musculus | 14 | ALA4196173 | single protein format | Scientific Literature | |
2. | ALA4200948 | Binding | Binding affinity to IDE E111Q mutant (unknown origin) using N-terminal FITC-labeled compound after 2 hrs in absence of light at 298 K by fluorescence polarization assay | Homo sapiens | 1 | ALA4196173 | single protein format | Scientific Literature | |
3. | ALA4200949 | Binding | Selectivity ratio of IC50 for ECE-1 (unknown origin) to IC50 for mouse His-tagged IDE (42 to 1019 residues) | 1 | ALA4196173 | assay format | Scientific Literature | ||
4. | ALA4200950 | Binding | Selectivity ratio of IC50 for ACE (unknown origin) to IC50 for mouse His-tagged IDE (42 to 1019 residues) | 1 | ALA4196173 | assay format | Scientific Literature | ||
5. | ALA4200951 | Binding | Inhibition of IDE (unknown origin) assessed as potentiation of insulin-induced AKT phosphorylation in rat skeletal muscle cells at 100 uM preincubated for 10 mins followed insulin addition measured by Western blot analysis | Homo sapiens | 1 | ALA4196173 | cell-based format | Scientific Literature | |
6. | ALA4200952 | Binding | Selectivity ratio of IC50 for NEP (unknown origin) to IC50 for mouse His-tagged IDE (42 to 1019 residues) | 1 | ALA4196173 | assay format | Scientific Literature | ||
7. | ALA4200953 | ADME | Drug uptake in human HeLa cells at 5 uM using FITC-labeled compound after 2 hrs at 310 K by DAPI-staining based confocal microscopy | Homo sapiens | 4 | ALA4196173 | cell-based format | Scientific Literature | |
8. | ALA4200954 | ADME | Drug uptake in human HeLa cells at 5 uM using FITC-labeled compound after 2 hrs at 310 K by trypan blue-fluorescence based FACS analysis | Homo sapiens | 4 | ALA4196173 | cell-based format | Scientific Literature | |
9. | ALA4200955 | ADME | Drug uptake in human HeLa cells at 5 uM using FITC-labeled compound after 2 hrs at 310 K by LC-MS analysis | Homo sapiens | 1 | ALA4196173 | cell-based format | Scientific Literature | |
10. | ALA4200956 | ADME | Cytotoxicity against human HeLa cells assessed as reduction in cell viability at <300 uM after 24 hrs at 310 K by MTT assay | Homo sapiens | 2 | ALA4196173 | cell-based format | Scientific Literature | |
11. | ALA4200957 | ADME | Hemolytic activity against mouse RBC at 300 uM after 1 hr at 310 K | Mus musculus | 3 | ALA4196173 | cell-based format | Scientific Literature | |
12. | ALA4200958 | ADME | Metabolic stability in 25% mouse serum assessed as compound remaining at 250 uM up to 24 hrs by LC-MS analysis | Mus musculus | 2 | ALA4196173 | cell-free format | Scientific Literature | |
13. | ALA4200959 | Binding | Inhibition of IDE (unknown origin) assessed as potentiation of insulin-induced AKT phosphorylation in rat skeletal muscle cells at 100 uM preincubated up to 12 hrs followed by insulin addition and measured after 10 mins by Western blot analysis | Homo sapiens | 1 | ALA4196173 | cell-based format | Scientific Literature | |
14. | ALA4200960 | Binding | Inhibition of IDE (unknown origin)-mediated FITC-insulin degradation in rat skeletal muscle cells at 100 uM after 10 mins at 310 K by DAPI-staining based fluorescent inverted microscopic imaging analysis | Homo sapiens | 1 | ALA4196173 | cell-based format | Scientific Literature | |
15. | ALA4200961 | Toxicity | Toxicity in lean C57BL/6J mouse assessed as behavioral changes at 80 mg/kg, ip | Mus musculus | 1 | ALA4196173 | organism-based format | Scientific Literature | |
16. | ALA4200962 | Toxicity | Toxicity in lean C57BL/6J mouse assessed as body weight change at 80 mg/kg, ip after 3 days | Mus musculus | 1 | ALA4196173 | organism-based format | Scientific Literature | |
17. | ALA4200963 | Functional | Anti-diabetic activity in DIO C57BL/6J mouse model assessed as reduction in glucose levels at 80 mg/kg, ip administered 30 min prior to glucose stimulation measured up to 120 mins post glucose injection by GTT | Mus musculus | 1 | ALA4196173 | organism-based format | Scientific Literature | |
18. | ALA4200964 | ADME | Effect on glucose levels in lean C57BL/6J mouse at 80 mg/kg, ip administered 30 min prior to glucose stimulation measured up to 120 min post glucose injection by GTT | Mus musculus | 1 | ALA4196173 | organism-based format | Scientific Literature | |
19. | ALA4200965 | Functional | Hypoglycemic activity in lean C57BL/6J mouse at 80 mg/kg, ip administered 30 min prior to insulin injection measured up to 75 mins post insulin injection by ITT | Mus musculus | 1 | ALA4196173 | organism-based format | Scientific Literature | |
20. | ALA4200966 | ADME | Drug uptake in brain parenchyma of DIO C57BL/6J mouse at 80 mg/kg, iv using FITC-labeled compound by two-photon microscopic analysis | Mus musculus | 1 | ALA4196173 | organism-based format | Scientific Literature |